del Moral R G, Andujar M, Ramírez C, Gómez-Morales M, Masseroli M, Aguilar M, Olmo A, Arrebola F, Guillén M, García-Chicano M J, Nogales F F, O'Valle F
Department of Pathology, School of Medicine and University Hospital, Granada, Spain.
Am J Pathol. 1997 Dec;151(6):1705-14.
P-glycoprotein (P-gp) expels hydrophobic substances from the cell, including chemotherapeutic agents and immunosuppressants such as cyclosporin A (CsA) and FK506. Exposure of cultured renal tubular cells to CsA induces P-gp overexpression in cell membranes. Angiotensin II has recently been implicated as the principal factor responsible for progression of interstitial fibrosis induced by CsA. To investigate the in vivo relationships between histological lesions, P-gp overexpression, and intrarenal angiotensin II deposits, we developed a model of chronic CsA toxicity in Sprague-Dawley rats treated with 25 mg/kg/day CsA for 28 and 56 days and fed either a standard maintenance diet or a low-salt diet. Immunohistochemical methods were used to study the expression of P-gp in renal tubular cells and the appearance of intrarenal angiotensin II deposits. Rats treated with CsA developed chronic nephrotoxicity lesions that were more evident in the group fed the low-salt diet. Treatment with CsA induced overexpression of P-gp in tubular cells of the kidney that increased with time. We found that immunohistochemical expression of P-gp was slightly more severe in rats fed a low-salt diet. Intrarenal deposits of angiotensin II were more evident in rats treated with CsA; these deposits also increased with time. This finding was also more relevant in rats given the low-salt diet. The up-regulation of P-gp was inversely related to the incidence of hyaline arteriopathy (r = -0.65; P < 0.05), periglomerular (r = -0.58; P < 0.05) and peritubular fibrosis (r = -0.63; P < 0.05), and intrarenal angiotensin H deposits in animals with severe signs of nephrotoxicity (r = -0.65; P < 0.05). These results support the hypothesis that the role of P-gp as a detoxicant in renal cells may be related to mechanisms that control the cytoplasmic removal of both toxic metabolites from CsA and those originating from the catabolism of signal transduction proteins (methylcysteine esters), which are produced as a result of ras activation in presence of angiotensin II.
P-糖蛋白(P-gp)可将包括化疗药物以及免疫抑制剂(如环孢素A(CsA)和FK506)在内的疏水性物质排出细胞。将培养的肾小管细胞暴露于CsA可诱导细胞膜上P-gp的过表达。最近有研究表明,血管紧张素II是CsA诱导的间质纤维化进展的主要因素。为了研究组织学损伤、P-gp过表达和肾内血管紧张素II沉积之间的体内关系,我们建立了一个慢性CsA毒性模型,用25mg/kg/天的CsA处理Sprague-Dawley大鼠28天和56天,并分别给予标准维持饮食或低盐饮食。采用免疫组织化学方法研究肾小管细胞中P-gp的表达以及肾内血管紧张素II沉积的情况。用CsA处理的大鼠出现了慢性肾毒性损伤,在喂食低盐饮食的组中更为明显。CsA处理可诱导肾脏肾小管细胞中P-gp的过表达,且随时间增加。我们发现,喂食低盐饮食的大鼠中P-gp的免疫组织化学表达略更严重。CsA处理的大鼠肾内血管紧张素II沉积更明显;这些沉积也随时间增加。这一发现在给予低盐饮食的大鼠中也更显著。P-gp的上调与透明样动脉病的发生率呈负相关(r = -0.65;P < 0.05),与肾小球周围(r = -0.58;P < 0.05)和肾小管周围纤维化(r = -0.63;P < 0.05)以及肾毒性严重体征动物的肾内血管紧张素II沉积呈负相关(r = -0.65;P < 0.05)。这些结果支持以下假说:P-gp作为肾细胞中一种解毒剂的作用可能与控制从CsA中清除有毒代谢产物以及从信号转导蛋白(甲基半胱氨酸酯)的分解代谢中产生的有毒代谢产物(在血管紧张素II存在下由ras激活产生)的胞质清除机制有关。